Attached files
file | filename |
---|---|
8-K - FORM 8-K - ALBEMARLE CORP | d441468d8k.htm |
EX-99.4 - ALBEMARLE CORPORATION AND SUBSIDIARIES SEGMENT INCOME RECONCILIATION - ALBEMARLE CORP | d441468dex994.htm |
EX-99.5 - ALBEMARLE CORPORATION AND SUBSIDIARIES EARNINGS PER DILUTED SHARE - ALBEMARLE CORP | d441468dex995.htm |
EX-99.3 - ALBEMARLE CORPORATION AND SUBSIDIARIES SEGMENT INCOME RECONCILIATION - ALBEMARLE CORP | d441468dex993.htm |
EX-99.6 - ALBEMARLE CORPORATION AND SUBSIDIARIES EARNINGS PER DILUTED SHARE - ALBEMARLE CORP | d441468dex996.htm |
EX-99.7 - PRESS RELEASE - ALBEMARLE CORP | d441468dex997.htm |
EX-99.2 - ALBEMARLE CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF INCOME - ALBEMARLE CORP | d441468dex992.htm |
Exhibit 99.1
Albemarle Corporation and Subsidiaries
CONSOLIDATED STATEMENTS OF INCOME
(In Thousands, Except Per Share Amounts; Unaudited)
Nine Months Ended September 30, 2012 |
As Previously Reported |
Effect of Accounting Change |
As Adjusted | |||||||||
Net sales |
$ | 2,057,824 | $ | | $ | 2,057,824 | ||||||
Cost of goods sold |
1,352,495 | (12,689 | ) | 1,339,806 | ||||||||
|
|
|
|
|
|
|||||||
Gross profit |
705,329 | 12,689 | 718,018 | |||||||||
Selling, general and administrative expenses |
215,298 | (26,155 | ) | 189,143 | ||||||||
Research and development expenses |
59,791 | | 59,791 | |||||||||
Restructuring and other charges |
101,211 | (6,508 | ) | 94,703 | ||||||||
|
|
|
|
|
|
|||||||
Operating profit |
329,029 | 45,352 | 374,381 | |||||||||
Interest and financing expenses |
(25,134 | ) | | (25,134 | ) | |||||||
Other income, net |
1,564 | | 1,564 | |||||||||
|
|
|
|
|
|
|||||||
Income before income taxes and equity in net income of unconsolidated investments |
305,459 | 45,352 | 350,811 | |||||||||
Income tax expense |
76,804 | 16,578 | 93,382 | |||||||||
|
|
|
|
|
|
|||||||
Income before equity in net income of unconsolidated investments |
228,655 | 28,774 | 257,429 | |||||||||
Equity in net income of unconsolidated investments (net of tax) |
29,233 | | 29,233 | |||||||||
|
|
|
|
|
|
|||||||
Net income |
$ | 257,888 | $ | 28,774 | $ | 286,662 | ||||||
Net income attributable to noncontrolling interests |
(12,852 | ) | | (12,852 | ) | |||||||
|
|
|
|
|
|
|||||||
Net income attributable to Albemarle Corporation |
$ | 245,036 | $ | 28,774 | $ | 273,810 | ||||||
|
|
|
|
|
|
|||||||
Basic earnings per share |
$ | 2.75 | $ | 0.32 | $ | 3.07 | ||||||
|
|
|
|
|
|
|||||||
Diluted earnings per share |
$ | 2.72 | $ | 0.32 | $ | 3.04 | ||||||
|
|
|
|
|
|
|||||||
Weighted-average common shares outstanding basic |
89,246 | | 89,246 | |||||||||
|
|
|
|
|
|
|||||||
Weighted-average common shares outstanding diluted |
89,959 | | 89,959 | |||||||||
|
|
|
|
|
|
|||||||
Cash dividends declared per share of common stock |
$ | 0.60 | $ | | $ | 0.60 | ||||||
|
|
|
|
|
|
Exhibit 99.1 | ||
Albemarle Corporation and Subsidiaries |
CONSOLIDATED STATEMENTS OF INCOME
(In Thousands, Except Per Share Amounts; Unaudited)
Year Ended December 31, 2011 |
As Previously Reported |
Effect of Accounting Change |
As Adjusted | |||||||||
Net sales |
$ | 2,869,005 | $ | | $ | 2,869,005 | ||||||
Cost of goods sold |
1,891,946 | 22,112 | 1,914,058 | |||||||||
|
|
|
|
|
|
|||||||
Gross profit |
977,059 | (22,112 | ) | 954,947 | ||||||||
Selling, general and administrative expenses |
312,136 | 47,934 | 360,070 | |||||||||
Research and development expenses |
77,083 | | 77,083 | |||||||||
|
|
|
|
|
|
|||||||
Operating profit |
587,840 | (70,046 | ) | 517,794 | ||||||||
Interest and financing expenses |
(37,574 | ) | | (37,574 | ) | |||||||
Other income, net |
357 | | 357 | |||||||||
|
|
|
|
|
|
|||||||
Income before income taxes and equity in net income of unconsolidated investments |
550,623 | (70,046 | ) | 480,577 | ||||||||
Income tax expense |
130,014 | (25,880 | ) | 104,134 | ||||||||
|
|
|
|
|
|
|||||||
Income before equity in net income of unconsolidated investments |
420,609 | (44,166 | ) | 376,443 | ||||||||
Equity in net income of unconsolidated investments (net of tax) |
43,754 | | 43,754 | |||||||||
|
|
|
|
|
|
|||||||
Net income |
$ | 464,363 | $ | (44,166 | ) | $ | 420,197 | |||||
Net income attributable to noncontrolling interests |
(28,083 | ) | | (28,083 | ) | |||||||
|
|
|
|
|
|
|||||||
Net income attributable to Albemarle Corporation |
$ | 436,280 | $ | (44,166 | ) | $ | 392,114 | |||||
|
|
|
|
|
|
|||||||
Basic earnings per share |
$ | 4.82 | $ | (0.49 | ) | $ | 4.33 | |||||
|
|
|
|
|
|
|||||||
Diluted earnings per share |
$ | 4.77 | $ | (0.49 | ) | $ | 4.28 | |||||
|
|
|
|
|
|
|||||||
Weighted-average common shares outstanding basic |
90,522 | | 90,522 | |||||||||
|
|
|
|
|
|
|||||||
Weighted-average common shares outstanding diluted |
91,522 | | 91,522 | |||||||||
|
|
|
|
|
|
|||||||
Cash dividends declared per share of common stock |
$ | 0.67 | $ | | $ | 0.67 | ||||||
|
|
|
|
|
|
Exhibit 99.1 | ||
Albemarle Corporation and Subsidiaries |
CONSOLIDATED STATEMENTS OF INCOME
(In Thousands, Except Per Share Amounts; Unaudited)
Year Ended December 31, 2010 |
As Previously Reported |
Effect of Accounting Change |
As Adjusted | |||||||||
Net sales |
$ | 2,362,764 | $ | | $ | 2,362,764 | ||||||
Cost of goods sold |
1,616,842 | 4,012 | 1,620,854 | |||||||||
|
|
|
|
|
|
|||||||
Gross profit |
745,922 | (4,012 | ) | 741,910 | ||||||||
Selling, general and administrative expenses |
265,722 | 8,893 | 274,615 | |||||||||
Research and development expenses |
58,394 | | 58,394 | |||||||||
Restructuring and other charges |
6,958 | | 6,958 | |||||||||
|
|
|
|
|
|
|||||||
Operating profit |
414,848 | (12,905 | ) | 401,943 | ||||||||
Interest and financing expenses |
(25,533 | ) | | (25,533 | ) | |||||||
Other income, net |
2,788 | | 2,788 | |||||||||
|
|
|
|
|
|
|||||||
Income before income taxes and equity in net income of unconsolidated investments |
392,103 | (12,905 | ) | 379,198 | ||||||||
Income tax expense |
92,719 | (4,963 | ) | 87,756 | ||||||||
|
|
|
|
|
|
|||||||
Income before equity in net income of unconsolidated investments |
299,384 | (7,942 | ) | 291,442 | ||||||||
Equity in net income of unconsolidated investments (net of tax) |
37,975 | | 37,975 | |||||||||
|
|
|
|
|
|
|||||||
Net income |
$ | 337,359 | $ | (7,942 | ) | $ | 329,417 | |||||
Net income attributable to noncontrolling interests |
(13,639 | ) | | (13,639 | ) | |||||||
|
|
|
|
|
|
|||||||
Net income attributable to Albemarle Corporation |
$ | 323,720 | $ | (7,942 | ) | $ | 315,778 | |||||
|
|
|
|
|
|
|||||||
Basic earnings per share |
$ | 3.54 | $ | (0.08 | ) | $ | 3.46 | |||||
|
|
|
|
|
|
|||||||
Diluted earnings per share |
$ | 3.51 | $ | (0.08 | ) | $ | 3.43 | |||||
|
|
|
|
|
|
|||||||
Weighted-average common shares outstanding basic |
91,393 | | 91,393 | |||||||||
|
|
|
|
|
|
|||||||
Weighted-average common shares outstanding diluted |
92,184 | | 92,184 | |||||||||
|
|
|
|
|
|
|||||||
Cash dividends declared per share of common stock |
$ | 0.56 | $ | | $ | 0.56 | ||||||
|
|
|
|
|
|